Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2021

Oct 13, 2021

30016_dirs_2021-10-13_29326e3c-c916-4751-a12a-61c278245322.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-10-11

Reporting Person: Claflin Bruce L. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-11 Common Stock M 1921 $160.28 Acquired 1921 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-11 Non-Qualified Stock Option (right-to-buy) $160.28 M 1921 Disposed 2027-05-02 Common Stock (1921) Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018.

F2: Not applicable.